Anna Latorre

Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson’s Disease

Giorgio Vivacqua, Anna Latorre, Antonio Suppa et al. · PLoS ONE · 2016 · 133 citations · Full text

Neurochemical Biomarkers, Clinical Neuroscience, Mds-unified Parkinson +16

Non-invasive suppression of essential tremor via phase-locked disruption of its temporal coherence

Sebastian R. Schreglmann, David Wang, Robert L. Peach et al. · Nature Communications · 2021 · 124 citations · Full text

Poor self-awareness of levodopa-induced dyskinesias in Parkinson's disease: Clinical features and mechanisms

Sara Pietracupa, Alfonso Fasano, Giovanni Fabbrini et al. · Parkinsonism & Related Disorders · 2013 · 63 citations

Neurological Disorder, Parkinson Disease, Clinical Features +7

Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study

Alessandro Tessitore, Pietro Marano, Nicola Modugno et al. · Journal of Neurology · 2018 · 62 citations · Full text

Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up

Mariachiara Sensi, Giovanni Cossu, Francesca Mancini et al. · Parkinsonism & Related Disorders · 2017 · 57 citations · Full text

Which Patients, Italian Multicentre Survey, Gastroenterology +5